# The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI

> **NCT07386496** · NA · NOT_YET_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 250 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **PROCEDURE:** MRI+PSMA-guided approach
- **PROCEDURE:** MRI-guided approach

## Key facts

- **NCT ID:** NCT07386496
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07386496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07386496, "The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07386496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*